-+ 0.00%
-+ 0.00%
-+ 0.00%

Eton Pharmaceuticals FY2026 Revenue expected to be more than $145.000M vs $121.326M Est

Benzinga·08/13/2026 20:07:29
Listen to the news
Eton Pharmaceuticals (NASDAQ:ETON) FY2026 Revenue expected to be more than $145.000M vs $121.326M Est